NEWS

News Articles

The 2020 We Work for Health Champion Awards showcase the best of our industry

August 27, 2020

We are living through an extraordinary moment as COVID-19 continues to spread across the United States. During this time, frontline and essential workers across industries have bravely stepped up to meet the urgent needs of our society: from the emergency room to the supermarket to the post office, these everyday heroes deserve our gratitude and…

Read More

NIH establishes Centers for Research in Emerging Infectious Diseases

August 27, 2020

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced that it has awarded 11 grants with a total first-year value of approximately $17 million to establish the Centers for Research in Emerging Infectious Diseases (CREID). The global network will involve multidisciplinary investigations into how and where…

Read More

NCI, Cancer Research UK launch Cancer Grand Challenges partnership to support bold new ideas for cancer research

August 27, 2020

The National Cancer Institute (NCI), part of the National Institutes of Health, will partner with Cancer Research UK to fund Cancer Grand Challenges, an international initiative to address profound and unanswered questions in cancer research. Through Cancer Grand Challenges, NCI and Cancer Research UK will seek novel ideas from multidisciplinary research teams from around the…

Read More

Vizzia Technologies Achieves Inc. 5000 for Third Consecutive Year

August 25, 2020

Vizzia Technologies, a leading software and managed service provider of real-time location systems (RTLS) for healthcare organizations, was recognized on the 2020 Inc. 5000 list of fastest-growing private companies in America. This is Vizzia’s third consecutive appearance on the prestigious Inc. 5000 list, due to the company’s three-year revenue growth of 98 percent. According to Inc. magazine,…

Read More

GeoVax Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients

August 24, 2020

GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, announced today initiation of a Phase 1 clinical study of a combination therapy in HIV-positive patients utilizing GeoVax’s novel boost component MVA62B. The study is a collaboration of researchers led by Dr. Steven Deeks, Professor of Medicine in Residence at…

Read More

Quest Diagnostics and Quest Diagnostics Foundation Launch Initiative to Reduce Health Disparities in Underserved Communities

August 24, 2020

Quest to dedicate more than $100 million to expand access to testing, partner to help those hit hardest by COVID-19 and fund Foundation initiatives Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, and the Quest Diagnostics Foundation, today announced a wide-ranging initiative to address and reduce health disparities in underserved…

Read More